Background image



Conferences we are attending this month

posted by

USDTL attends upwards of fifty conferences a year. It is our way of supporting the communities we serve and touching base with clients old and new.

The month of October is an extraordinary time for us. We will have personnel at nine conferences.
Starting Tuesday, October 9, Kendyll Vanzandt, Client Services Representative will be in Grand Rapids, Michigan at the Amway Grand Hotel for the annual CoLap conference.
Thursday, October 11, Gary Bohl, Forensic Account Executive, will be in Newport Beach for the West Coast Behavioral Health and Addiction Disorders conference.
Saturday, October 13, Douglas Lewis, USDTL President and Scientific Director, and Victoria Lewis Marketing Sales Associate, will be in Washington, D.C. for the ASA meeting.
Monday, October 15, Bob Demaree, Clinical Projects Manager, will be in Florida at the FANNP conference. 
Wednesday, October 17th, Kendyll will be at NANN in Palm Springs and Bob will join her on the 18th.
Thursday, October 18th, Gary will be at TAAP in Houston, TX.
Wednesday, October 24th, Douglas and Victoria Lewis will be at CCLMA in Chicago.
Thursday, October 25th, Gary Bohl will be at his first international show, AMA, CMA, BMA International in Montreal, CA.
Sunday, October 28th, Bob will be at the Fetus and Newborn conference, talking to clients about our CordStat panels.

It’s a busy month. We are proud to serve. If you are at any of these shows, please drop by and say hello.


Ask Our Toxicologists – Hair Testing

posted by

Q: I received a report that says “REJECTED” and “Profile not indicated- fax request to lab”. What does that mean? Has the specimen been destroyed? What should I do?

A: One piece of information that must be present on the Requisition Form is the Test Profile Requested. The lab is not allowed to pick and choose which panels to run on your behalf. We must obtain that information from the client in writing.

If the requisition form does not indicate which test to run, we reject the specimen with a request for the client to notify USDTL which profile to run on the specimen. You may notify the lab of the test profile you desire by fax or email. Remember to include multiple pieces of identification on the request. One fail-safe and quick way to notify the lab of which test to run is to note the desired profile on your fax copy and fax that over to the lab.

These specimens are retained for at least one week. Specimen requests not resolved within one week are scheduled for destruction along with the week-old negative specimens. One alternative to consider is the selection of a “Default Profile”. Having this information documented and on file at the laboratory allows the laboratory to assign a default profile when one is not indicated on the Requisition Form.

Smiles – new killer drug

What parents need to know about new drug trends in kids: Glass cleaner, bath salts and “Skittle parties” … 

Rampant abuse of alcohol and prescription drugs in the military 

Baby Boomers Rediscovering Old #Addictions – 

United States Drug Testing Laboratories, Inc.’s BloodSpot™ Collection Kit
Now Quick and Easy

DES PLAINES, IL (July 16, 2012)-
United States Drug Testing Laboratories (USDTL), a reference laboratory specializing in alcohol and drugs of abuse testing, released a new BloodSpot™ Collection Kit for testing PEth a direct biomarker for beverage alcohol consumption. The kit helps treatment centers, researchers and professional health programs by offering a choice when it comes to sample collection. Previously the blood spots had an hour dry time before they could be sealed and shipped.  USDTL now adds a drying box to the kit for immediate seal and ship.

Blood spot collection is a simple, unadulterable, observed collection for our PEthStat® Assay.

Phosphatidylethanol (PEth) is an abnormal phospholipid formed in cell tissues following alcohol exposure. PEth in blood exists as a component of the red cell membrane. PEth is a mid to long-term alcohol biomarker measurable after engaging in risky alcohol drinking behavior. A positive result is an indication of binge alcohol drinking during the 2-3 weeks prior to the collection of the blood or blood spot.

While ethyl glucuronide (EtG) is a sensitive and valuable assay for those individuals in treatment programs for alcohol abuse, recent studies have indicated that low level positive EtG results can be produced by certain agents like hand sanitizers and mouth wash. The PEthStat assay helps to discriminate between incidental exposure and intentional alcohol ingestion. The volume of alcohol required to trigger a positive PEth result is far above the level commonly attained by incidental exposure. Sample amount is 5 dried blood spots on USDTL-provided filter paper.

 USDTL has been a leader in the drug testing industry since 1991 through research and assay development. The laboratory has an active research program supported, in part, by the National Institute of Drug Abuse and the National Institute of Alcohol Abuse and Alcoholism. For more information and a sample kit call Client Services at 800-235-2367.


News You Can Use – Forensic

posted by

Officials in #Russia concerned about new synthetic #marijuana called “spice:” @AP

Painkiller abuse linked to #depression & #suicide in college students:

Evidence mounts: Methadone Risky in Chronic Pain:

Almost 1500 packages of synthetic drugs seized in Illinois: LegalNewsline – Almost 1500 packages of synthetic dr…

On an avg day in June or July, more than 4,800 youths used marijuana for the first time

On an avg day in June or July, more than 5,000 youths smoked cigarettes for the first time

On an avg day in June or July, more than 11,000 youths used alcohol for the first time


Newborn News You Can Use:

posted by

Prescription Drug Abuse Among Pregnant Women:

Addicted Mom on Baby’s Withdrawl; It’s All My Fault:

Prescription Pill Epidemic Impacts Babies:


News You Can Use:

Bill Banning Synthetic Drugs Passes Senate, Awaits President’s Signature

By Join Together Staff | June 29, 2012 | reprinted from:

The U.S. Senate passed a bill outlawing synthetic drugs this week, and awaits President Obama’s signature, The Cleveland Plain Dealer reports. The Synthetic Drug Abuse Prevention Act of 2012 bans drugs such as “bath salts” and synthetic marijuana at the federal level.

According to a news release from the office of Senator Charles Schumer of New York, the amendment included three bills relating to synthetic substances: one for bath salts, one for synthetic marijuana, and one for synthetic hallucinogens. Click on link above for more information.


News You Can Use – Drug Testing

posted by

A study out of WI shows the benefits of monitoring multiple DUI offenders:

Drunk Driving can indicate addiction problem: